Cellink founders raise $1.4 million for AI lab-analysis startup Aventix
What's the deal? AventixDealroom has a profile for this one. Try Dealroom →, a Mölndal-based bioanalysis startup, has raised €1.2 million — about US$1.64M, or roughly $1.4 million — in an early-stage round. Danish impact investor Kost CapitalDealroom has a profile for this one. Try Dealroom →, led by Sweden's Bodil Sidén, headed the round alongside Voima VenturesDealroom has a profile for this one. Try Dealroom →.
What's the endgame? Aventix builds tools that use AI to improve lab analyses, combining sensors with software to deliver faster, more precise experiment results. It says the approach can reduce errors and support better-informed decisions across chemistry, agriculture, pharmaceuticals, and cosmetics.
The product: The funding will finance the commercial rollout of Aventix's first product, Scarlett 01. "Scarlett 01 is just the first proof of what this platform can be," said Sidén, a partner at Kost Capital (translated from Swedish).
Who's behind it? Aventix was founded by serial entrepreneurs Erik Gatenholm and Hector Martinez, who co-founded Cellink, later Bico GroupDealroom has a profile for this one. Try Dealroom →.
Why now? "The pace of scientific discovery is increasing, but progress will increasingly depend on how efficiently we can collect and analyse reliable data to develop, train, and apply AI models," Gatenholm said (translated from Swedish).
The signal: The round pairs proven founders with an impact-focused investor betting that better data infrastructure — not just bigger models — will shape the next wave of scientific AI.
Read more: breakit.se
Image credit: Generated with Gemini
